Occupational epidemiology;Epidemiologie in der Arbeitswelt

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 51, Issue 3, 2008, Pages 255-265

  Ahrens, Wolfgang ^a,b   Behrens, T ^a   Mester, B ^a   Schmeisser N ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

Author keywords

Biomarkers; Exposure assessment; Prevention; Threshold limit values; Workplace health promotion

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; GERMANY; HUMAN; MAXIMUM ALLOWABLE CONCENTRATION; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE;

BIOLOGICAL MARKERS; GERMANY; HUMANS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; THRESHOLD LIMIT VALUES;

EID: 41849083716     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-008-0455-3     Document Type: Article

References (49)

1. Härting F, Hesse W (1879) Der Lungenkrebs, die Bergkrankheit in den Schneeberger Gruben. Vierteljahrsschrift Gerichtliche Medizin und Öffentliches Sanitätswesen 30/31:296-309, 102-132, 313-337
2. Dobson J (1972) Percivall Pott. Ann R Coll Surg Engl 50(1):54-65
3. Franco G, Franco F (2001) Bernardino Ramazzini: The father of occupational medicine. Am J Public Health 91(9):1382
4. Merletti F, Mirabelli D (2004) Occupational exposures. In: International Union Against cancer (UICC) (Hrsg.) Evidence-based cancer prevention: Strategies for NGOs. UICC, Genf, pp 132-147
5. Roller M, Akkan Z, Hassauer M, Kalberlah F (2006) Risikoextrapolation vom Versuchstier auf den Menschen bei Kanzerogenen. Wirtschaftsverlag NW, Bremerhaven
6. Frentzel-Beyme R, Thiess AM, Wieland R (1978) Survey of mortality among employees engaged in the manufacture of styrene and polystyrene at the BASF Ludwigshafen works. Scand J Work Environ Health 4 (Suppl 2):231-239
7. Frentzel-Beyme R (1983) Lung cancer mortality of workers employed in chromate pigment factories. A multicentric European epidemiological study. J Cancer Res Clin Oncol 105(2):183-188
8. Manz A (1976) Harnwegskarzinome bei Beschäftigten der Gasindustrie. MMW Munch Med Wochenschr 118(3):65-68
9. Manz A (1984) Krebsrisiko bei Ofenblockarbeitern von Kokereibetrieben - Ergebnisse einer Kohortenstudie. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie 34(2):34-41
10. Woitowitz HJ, Beierl L, Rathgeb M, et al. (1981) Asbestos-related diseases in the Federal Republic of Germany. Am J Ind Med 2(1):71-78
11. Ahrens W, Jöckel KH, Pohlabeln H, et al. (1996) Assessment of exposure to asbestos in a casecontrol study of lung cancer: comparison of supplementary questionnaires and an exposure check-list. Occupational Hygiene 3:125-136
12. Jöckel KH, Ahrens W, Jahn I, et al. (1998) Occupational risk factors for lung cancer: a case-control study in West Germany. Int J Epidemiol 27(4):549-560
13. Pesch B, Haerting J, Ranft U, et al. (2000) Occupational risk factors for renal cell carcinoma: agentspecific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int J Epidemiol 29(6):1014-1024
14. Miller A, Goff Jr D, Bammann K, Wild P (2005) Cohort studies. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Berlin Heidelberg New York Tokyo, pp 253-285
15. Au WW, Sierra-Torres CH, Cajas-Salazar N, et al. (1999) Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ Health Perspect 107(6):501-505
16. Jahn I, Jöckel K, Bocter N, Müller W (1995) Studie zur Verbesserung der Validität und Reliabilität der amtlichen Todesursachenstatistik. Nomos, Baden- Baden
17. Klug SJ, Zeeb H, Blettner M (2003) Neue Möglichkeit der Recherche von Todesursachen in Deutschland über Statistische Landesämter am Beispiel einer retrospektiven Kohortenstudie. Gesundheitswesen 65(4):243-249
18. Giersiepen K, Brünings-Kuppe C, Lehmann C (2004) Der Bremer Mortalitätsindex. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47(5):451-456
19. Becker N (2002) Follow-up-Studien in Deutschland: Erfahrungsbericht unter dem Gesichtspunkt der datenschutzrechtlichen Rahmenbedingungen. Informatik Biometrie Epidemiol Med Biol 33(1):36-44
20. Zeeb H, Klug SJ, Ahrens W, Straif K (2003) Followup Studien in Deutschland: Weitere Erfahrungen und neue Entwicklungen bei der Todesursachenrecherche. Informatik Biometrie Epidemiol Med Biol 34(4):612-618
21. Deeks J, Glanville J, Sheldon T (1996) CRD guidelines for those carrying out or commissioning reviews. Centre for Reviews and Dissemination York (ed). York Publishing Services Ltd, York
22. Breslow N (2004) Case-control studies. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Berlin Heidelberg New York Tokyo, pp 287-319
23. Stang A, Ahrens W, Jöckel KH (1999) Control response proportions in population-based casecontrol studies in Germany. Epidemiology 10(2):181-183
24. Parkin M, Bray F (2005) Descriptive Studies. In: Ahrens W, Pigeot I (eds) Springer, Berlin Heidelberg New York Tokyo, pp 157-230
25. Behrens T, Taeger D, Wellmann J, Keil U (2004) Different methods to calculate effect estimates in cross-sectional studies - a comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med 43(5):505-509
26. Ahrens W (1999) Retrospective assessment of occupational exposure in case-control studies. Development, evaluation and comparison of different methods. Ecomed, Landsberg
27. Cordier S, Stewart P (2004) Exposure assessment. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Berlin Heidelberg New York Tokyo, pp 437-462
28. Teschke K, Olshan AF, Daniels JL, et al. (2002) Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med 59(9):575-593
29. Ahrens W, Stewart P (2003) Retrospective exposure assessment. In: Nieuwenhuijsen M (ed) Exposure assessment in occupational and environmental epidemiology. Oxford University Press, Oxford New York
30. Macaluso M, Larson R, Lynch J, et al. (2004) Historical estimation of exposure to 1,3-butadiene, styrene, and dimethyldithiocarbamate among synthetic rubber workers. J Occup Environ Hyg 1(6):371-390
31. Kauppinen T, Toikkanen J, Pedersen D, et al. (2000) Occupational exposure to carcinogens in the European Union. Occup Environ Med 57(1):10-18
32. Burdorf A (2003) Analysis and modelling of personal exposures. In: Nieuwenhuijsen M (ed) Exposure assessment in occupational and environmental epidemiology. Oxford University Press, Oxford New York
33. Ahrens W, Jöckel KH, Brochard P, et al. (1993) Retrospective assessment of asbestos exposure - I. Case-control analysis in a study of lung cancer: efficiency of job-specific questionnaires and job exposure matrices. Int J Epidemiol 22(Suppl 2):S83-S95
34. Woitowitz HJ, Schäcke G, Woitowitz RH (1970) Rangmäßige Schätzung der Staubexposition und arbeitsmedizinische Epidemiologie. Staub Reinhaltung Luft 30:419-422
35. Hoffmann W, Latza U, Ahrens W, et al. (2002) Biologische Marker in der Epidemiologie: Begriffe, Anwendungen, Perspektiven (Teil I). Gesundheitswesen 64(2):99-107
36. Weisel C, Yu R, Roy A, Georgopoulos P (1996) Biomarkers of environmental benzene exposure. Environ Health Perspect 104(Suppl 6):1141-1146
37. Merzenich H, Hartwig A, Ahrens W, et al. (2001) Biomonitoring on carcinogenic metals and oxidative DNA damage in a cross-sectional study. Cancer Epidemiol Biomarkers Prev 10(5):515-522
38. Goode EL, Ulrich CM, Potter JD (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11(12):1513-1530
39. Hashibe M, Brennan P, Strange RC, et al. (2003) Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 12(12):1509-1517
40. Vineis P, Matullo G, Berwick M (2004) Molecular epidemiology. In: Ahrens W, Pigeot I (eds) Handbook of epidemiology. Springer, Berlin Heidelberg New York Tokyo, pp 1111-1138
41. Au WW, Lee E, Christiani DC (2005) Biomarker research in occupational health. J Occup Environ Med 47(2):145-153
42. Flesch-Janys D, Steindorf K, Gurn P, Becher H (1998) Estimation of the cumulated exposure to polychlorinated dibenzo-p-dioxins/furans and standardized mortality ratio analysis of cancer mortality by dose in an occupationally exposed cohort. Environ Health Perspect 106(Suppl 2):655-662
43. Goldbohm RA, Tielemans EL, Heederik D, et al. (2006) Risk estimation for carcinogens based on epidemiological data: a structured approach, illustrated by an example on chromium. Regul Toxicol Pharmacol 44(3):294-310
44. Lynge E, Afonso N, Kaerlev L, et al. (2005) European multi-centre case-control study on risk factors for rare cancers of unknown aetiology. Eur J Cancer 41(4):601-612
45. Blair A, Burg J, Foran J, et al. (1995) Guidelines for application of meta-analysis in environmental epidemiology. Regul Toxicol Pharmacol 22(2):189-197
46. Arbeitsgruppe Epidemiologische Methoden der Deutschen Gesellschaft für Epidemiologie (DGEpi) (2004) Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP); vgl. auch http://www.dgepi.de/ infoboard/ stellungnahmen.htm
47. Peltomäki P, Johansson M, Ahrens W, et al. (2003) Social context for workplace health promotion: feasibility considerations in Costa Rica, Finland, Germany, Spain and Sweden. Health Promot Int 18(2):115-126
48. Partanen T, Johansson M, Ahrens W, et al. (2002) Assessment of feasibility of workplace health promotion. Prev Med 35(3):232-240
49. BKK Bundesverband, Europäisches Informationszentrum (1999) Gesunde Mitarbeiter in gesunden Unternehmen. Erfolgreiche Praxis betrieblicher Gesundheitsförderung in Europa. Qualitätskriterien für die betriebliche Gesundheitsförderung. Eigenverlag, Essen